Valley National Advisers Inc Moderna, Inc. Transaction History

Valley National Advisers Inc

$554 Million
Q3 2024

A detailed history of Valley National Advisers Inc transactions in Moderna, Inc. stock. As of the latest transaction made, Valley National Advisers Inc holds 394 shares of MRNA stock, worth $16,059. This represents 0.0% of its overall portfolio holdings.

Number of Shares

394

Previous 484 18.6%

Holding current value

$16,059

Previous $57,000 54.39%

% of portfolio

0.0%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	SELL	$63.64 - $125.14 $5,727 - $11,262	-90 Reduced 18.6%	394 $26,000
Q2 2024 Jul 18, 2024	BUY	$101.21 - $166.61 $2,024 - $3,332	20 Added 4.31%	484 $57,000
Q1 2024 Apr 19, 2024	SELL	$85.37 - $115.44 $4,097 - $5,541	-48 Reduced 9.38%	464 $49,000
Q4 2023 Jan 25, 2024	SELL	$69.51 - $104.43 $1,807 - $2,715	-26 Reduced 4.83%	512 $50,000
Q3 2023 Nov 13, 2023	BUY	$96.41 - $126.61 $192 - $253	2 Added 0.37%	538 $56,000
Q2 2023 Jul 31, 2023	BUY	$118.5 - $160.53 $1,066 - $1,444	9 Added 1.71%	536 $66,000
Q1 2023 Apr 26, 2023	BUY	$135.66 - $197.02 $13,566 - $19,702	100 Added 23.42%	527 $73,000
Q4 2022 Jan 12, 2023	BUY	$118.38 - $210.04 $5,682 - $10,081	48 Added 12.66%	427 $79,000
Q3 2022 Nov 08, 2022	BUY	$118.07 - $194.18 $472 - $776	4 Added 1.07%	379 $51,000
Q2 2022 Jul 15, 2022	BUY	$117.13 - $176.59 $5,387 - $8,123	46 Added 13.98%	375 $65,000
Q1 2022 May 06, 2022	BUY	$126.46 - $235.05 $11,128 - $20,684	88 Added 36.51%	329 $57,000
Q4 2021 Feb 11, 2022	BUY	$225.82 - $368.51 $8,355 - $13,634	37 Added 18.14%	241 $61,000
Q3 2021 Nov 10, 2021	BUY	$221.9 - $484.47 $1,331 - $2,906	6 Added 3.03%	204 $79,000
Q2 2021 Aug 02, 2021	BUY	$129.91 - $234.98 $1,558 - $2,819	12 Added 6.45%	198 $47,000
Q1 2021 May 07, 2021	BUY	$109.18 - $185.98 $1,419 - $2,417	13 Added 7.51%	186 $24,000
Q4 2020 Feb 11, 2021	SELL	$65.74 - $169.86 $3,286 - $8,493	-50 Reduced 22.42%	173 $18,000
Q2 2020 Aug 10, 2020	SELL	$29.67 - $80.0 $5,162 - $13,920	-174 Reduced 43.83%	223 $14,000
Q1 2020 May 13, 2020	BUY	$17.78 - $31.58 $7,058 - $12,537	397 New	397 $12,000

Others Institutions Holding MRNA

# of Institutions

953

Shares Held

241M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15.9B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Valley National Advisers Inc, based on Form 13F filings with the SEC.

News

Stay updated on Valley National Advisers Inc with notifications on news.

Account

Valley National Advisers Inc Moderna, Inc. Transaction History